Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
thromboembolism
Research
Bear research reveals potential drug target for blood clots
A research team has used the blood of hibernating bears to discover how waxing and waning levels of a protein protect against venous thromboembolism.
Helen Floersh
Apr 18, 2023 9:00am
BMS, Janssen blood clot med aces proof-of-concept study
Nov 15, 2021 11:41am
Aidoc secures $66M to help meet demand for AI imaging programs
Jul 14, 2021 7:40am
Surmodics gets the blood flowing with $40M thrombectomy deal
Jul 7, 2021 10:05am
Abiomed gets Impella EUA for coronavirus-related heart failure
Jun 1, 2020 10:55am
Inari raises $27M to commercialize clot removal devices
Mar 30, 2018 7:56am
